- Home
- ZDAI vs SNSE Comparison
ZDAI vs SNSE Comparison
Compare ZDAI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- SNSE
- Stock Information
- Founded
- ZDAI 2022
- SNSE 2005
- Country
- ZDAI Hong Kong
- SNSE United States
- Employees
- ZDAI N/A
- SNSE N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- SNSE Health Care
- Exchange
- ZDAI Nasdaq
- SNSE Nasdaq
- Market Cap
- ZDAI 14.8M
- SNSE 14.5M
- IPO Year
- ZDAI 2024
- SNSE 2021
- Fundamental
- Price
- ZDAI $0.49
- SNSE $9.11
- Analyst Decision
- ZDAI
- SNSE Strong Buy
- Analyst Count
- ZDAI 0
- SNSE 4
- Target Price
- ZDAI N/A
- SNSE $72.50
- AVG Volume (30 Days)
- ZDAI 92.7K
- SNSE 63.9K
- Earning Date
- ZDAI 11-11-2025
- SNSE 11-13-2025
- Dividend Yield
- ZDAI N/A
- SNSE N/A
- EPS Growth
- ZDAI N/A
- SNSE N/A
- EPS
- ZDAI N/A
- SNSE N/A
- Revenue
- ZDAI $19,275,673.00
- SNSE N/A
- Revenue This Year
- ZDAI N/A
- SNSE N/A
- Revenue Next Year
- ZDAI N/A
- SNSE N/A
- P/E Ratio
- ZDAI N/A
- SNSE N/A
- Revenue Growth
- ZDAI 43.16
- SNSE N/A
- 52 Week Low
- ZDAI $0.37
- SNSE $5.00
- 52 Week High
- ZDAI $107.36
- SNSE $18.35
- Technical
- Relative Strength Index (RSI)
- ZDAI 37.51
- SNSE 43.94
- Support Level
- ZDAI $0.48
- SNSE $9.07
- Resistance Level
- ZDAI $0.53
- SNSE $11.86
- Average True Range (ATR)
- ZDAI 0.04
- SNSE 1.88
- MACD
- ZDAI -0.01
- SNSE -0.46
- Stochastic Oscillator
- ZDAI 7.66
- SNSE 0.48
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).